Brain endothelial PPARγ controls inflammation-induced CD4+ T cell adhesion and transmigration in vitro

Journal of Neuroimmunology

Volumn 190, Issue 1-2, 2007, Pages 34-43

  Klotz, Luisa ^a   Diehl, Linda ^a   Dani, Indra ^a   Neumann, Harald ^a   von Oppen, Nanette ^a   Dolf, Andreas ^a   Endl, Elmar ^a   Klockgether, Thomas ^a   Engelhardt, Britta ^b   Knolle, Percy ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Adhesion; Endothelial cells; Transcription factor; Transmigration

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; LENTIVIRUS VECTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; VASCULAR CELL ADHESION MOLECULE 1; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BRAIN; CD4+ T LYMPHOCYTE; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE ADHERENCE; LYMPHOCYTE MIGRATION; MOUSE; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BAGG ALBINO MOUSE; BRAIN ARTERY; CELL ADHESION; CELL LINE; DRUG ANTAGONISM; DRUG POTENTIATION; ENCEPHALITIS; GENE EXPRESSION; GENE VECTOR; GENETICS; IMMUNOLOGY; LENTIVIRINAE; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOPHYSIOLOGY; VASCULARIZATION;

ANIMALS; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CELL ADHESION; CELL LINE; CEREBRAL ARTERIES; CHEMOTAXIS, LEUKOCYTE; ENCEPHALITIS; ENDOTHELIAL CELLS; GENE EXPRESSION; GENETIC VECTORS; HYPOGLYCEMIC AGENTS; INTERCELLULAR ADHESION MOLECULE-1; LENTIVIRUS; MICE; MICE, INBRED BALB C; PPAR GAMMA; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 35448941464     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.07.017     Document Type: Article

References (33)

1. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., Koder A., and Evans R.M. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol. Cell 4 (1999) 585-595
2. Chawla A., Barak Y., Nagy L., Liao D., Tontonoz P., and Evans R.M. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 7 (2001) 48-52
3. Clark R.B., Bishop-Bailey D., Estrada-Hernandez T., Hla T., Puddington L., and Padula S.J. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. J. Immunol. 164 (2000) 1364-1371
4. Cunard R., Eto Y., Muljadi J.T., Glass C.K., Kelly C.J., and Ricote M. Repression of IFN-gamma expression by peroxisome proliferator-activated receptor gamma. J. Immunol. 172 (2004) 7530-7536
5. Diab A., Deng C., Smith J.D., Hussain R.Z., Phanavanh B., Lovett-Racke A.E., Drew P.D., and Racke M.K. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 168 (2002) 2508-2515
6. Engelhardt B., and Briskin M.J. Therapeutic targeting of alpha 4-integrins in chronic inflammatory diseases: tipping the scales of risk towards benefit?. Eur. J. Immunol. 35 (2005) 2268-2273
7. Engelhardt B., Vestweber D., Hallmann R., and Schulz M. E- and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis. Blood 90 (1997) 4459-4472
8. Engelhardt B., Laschinger M., Schulz M., Samulowitz U., Vestweber D., and Hoch G. The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin. J. Clin. Invest. 102 (1998) 2096-2105
9. Engelhardt B., Kempe B., Merfeld-Clauss S., Laschinger M., Furie B., Wild M.K., and Vestweber D. P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice. J. Immunol. 175 (2005) 1267-1275
10. Feinstein D.L., Galea E., Gavrilyuk V., Brosnan C.F., Whitacre C.C., Dumitrescu-Ozimek L., Landreth G.E., Pershadsingh H.A., Weinberg G., and Heneka M.T. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis. Ann. Neurol. 51 (2002) 694-702
11. Hemmer B., Archelos J.J., and Hartung H.P. New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev., Neurosci. 3 (2002) 291-301
12. Hohlfeld R., Meinl E., Weber F., Zipp F., Schmidt S., Sotgiu S., Goebels N., Voltz R., Spuler S., and Iglesias A. The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis. Neurology 45 (1995) S33-S38
13. Jackson S.M., Parhami F., Xi X.P., Berliner J.A., Hsueh W.A., Law R.E., and Demer L.L. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2094-2104
14. Jiang C., Ting A.T., and Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391 (1998) 82-86
15. Kliewer S.A., Sundseth S.S., Jones S.A., Brown P.J., Wisely G.B., Koble C.S., Devchand P., Wahli W., Willson T.M., Lenhard J.M., and Lehmann J.M. Fatty Acids and Eicosanoids Regulate Gene Expression Through Direct Interactions with Peroxisome Proliferator-activated Receptors Alpha and Gamma (1999)
16. Klotz L., Sastre M., Kreutz A., Gavrilyuk V., Klockgether T., Feinstein D.L., and Heneka M.T. Noradrenaline induces expression of peroxisome proliferator activated receptor gamma (PPARgamma) in murine primary astrocytes and neurons. J. Neurochem. 86 (2003) 907-916
17. Klotz L., Schmidt M., Giese T., Sastre M., Knolle P., Klockgether T., and Heneka M.T. Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor gamma levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients. J. Immunol. 175 (2005) 4948-4955
18. Kurebayashi S., Xu X., Ishii S., Shiraishi M., Kouhara H., and Kasayama S. A novel thiazolidinedione MCC-555 down-regulates tumor necrosis factor-alpha-induced expression of vascular cell adhesion molecule-1 in vascular endothelial cells. Atherosclerosis 182 (2005) 71-77
19. Lehmann J.M., Lenhard J.M., Oliver B.B., Ringold G.M., and Kliewer S.A. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272 (1997) 3406-3410
20. Marx N., Mach F., Sauty A., Leung J.H., Sarafi M.N., Ransohoff R.M., Libby P., Plutzky J., and Luster A.D. Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J. Immunol. 164 (2000) 6503-6508
21. Miller D.H., Khan O.A., Sheremata W.A., Blumhardt L.D., Rice G.P., Libonati M.A., Willmer-Hulme A.J., Dalton C.M., Miszkiel K.A., and O'Connor P.W. A controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 348 (2003) 15-23
22. Niino M., Iwabuchi K., Kikuchi S., Ato M., Morohashi T., Ogata A., Tashiro K., and Onoe K. Amelioration of Experimental Autoimmune Encephalomyelitis in C57BL/6 Mice by an Agonist of Peroxisome Proliferator-activated Receptor-gamma (2002)
23. Pasceri V., Wu H.D., Willerson J.T., and Yeh E.T. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation 101 (2000) 235-238
24. Reiss Y., Hoch G., Deutsch U., and Engelhardt B. T cell interaction with ICAM-1-deficient endothelium in vitro: essential role for ICAM-1 and ICAM-2 in transendothelial migration of T cells. Eur. J. Immunol. 28 (1998) 3086-3099
25. Ricote M., Li A.C., Willson T.M., Kelly C.J., and Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391 (1998) 79-82
26. Rohnelt R.K., Hoch G., Reiss Y., and Engelhardt B. Immunosurveillance modelled in vitro: naive and memory T cells spontaneously migrate across unstimulated microvascular endothelium. Int. Immunol. 9 (1997) 435-450
27. Rossi A., Kapahi P., Natoli G., Takahashi T., Chen Y., Karin M., and Santoro M.G. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403 (2000) 103-108
28. Takahashi K., Rochford C.D., and Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 201 (2005) 647-657
29. Verrier E., Wang L., Wadham C., Albanese N., Hahn C., Gamble J.R., Chatterjee V.K., Vadas M.A., and Xia P. PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase. Circ. Res. 94 (2004) 1515-1522
30. Von Knethen A., and Brune B. Activation of peroxisome proliferator-activated receptor gamma by nitric oxide in monocytes/macrophages down-regulates p47phox and attenuates the respiratory burst. J. Immunol. 169 (2002) 2619-2626
31. Wang N., Verna L., Chen N.G., Chen J., Li H., Forman B.M., and Stemerman M.B. Constitutive activation of peroxisome proliferator-activated receptor-gamma suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells (2001)
32. Wang P., Anderson P.O., Chen S., Paulsson K.M., Sjogren H.O., and Li S. Inhibition of the transcription factors AP-1 and NF-kappaB in CD4 T cells by peroxisome proliferator-activated receptor gamma ligands. Int. Immunopharmacol. 1 (2001) 803-812
33. Yednock T.A., Cannon C., Fritz L.C., Sanchez-Madrid F., Steinman L., and Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356 (1992) 63-66